Half of all peripheral intravenous lines in an Australian tertiary emergency department are unused: Pain with no gain?
MetadataShow full item record
Study objective: Our study aims to determine the incidence of unused peripheral intravenous cannulas inserted in the emergency department (ED). Methods: A retrospective cohort study using a structured electronic medical record review was performed in a 640-bed tertiary care hospital in Melbourne, Australia. During a 30-day period, all patients who had a peripheral intravenous cannula recorded as a procedure on their electronic medical record in the ED were included in this study. Results: Fifty percent of peripheral intravenous cannulas inserted in the ED were unused. Patients presenting with obstetric and gynecologic and neurologic symptoms were significantly more likely to have an unused cannula. Forty-three percent of patients admitted to the hospital with unused peripheral intravenous cannulas in the ED continued to have them unused 72 hours later. Conclusion: There is a high incidence of unused peripheral intravenous cannulas inserted in the ED. The risk of having an unused peripheral intravenous cannula is associated with the patient's presenting complaint. Efforts should be directed to reduce this rate of unused peripheral intravenous cannula insertion, especially in patients being admitted, to minimize the risk of complications.
Showing items related by title, author, creator and subject.
The prevalence of peripheral intravenous cannulae and pattern of use: A point prevalence in a private hospital settingWong, K.; Cooper, A.; Brown, Janie; Boyd, L.; Levinson, M. (2018)AIMS AND OBJECTIVES: To determine the prevalence and pattern of use of peripheral intravenous cannulae in hospital wards. BACKGROUND: Peripheral intravenous cannulae are commonly used in acute health care to directly ...
Thangavelu Rajan, Remya (2008)Objective: To retrospectively evaluate intravenous antifungal medications in paediatric patients in a public hospital for children.Method: Data relevant to the antifungal prescription were collected for all the patients ...
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illnessThe, I.; Litton, E.; Baker, S.; Erber, W.; Farmer, Shannon; Ferrier, J.; French, C.; Gummer, J.; Hawkins, D.; Higgins, A.; Hofmann, Axel; De Keulenaer, B.; McMorrow, J.; Olynyk, John; Richards, T.; Towler, S.; Trengove, R.; Webb, S.; The, A. (2016)Purpose: Both anaemia and allogenic red blood cell transfusion are common and potentially harmful in patients admitted to the intensive care unit. Whilst intravenous iron may decrease anaemia and RBC transfusion requirement, ...